Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube

Search

Highlights
In Focus

New frontiers in CLTI treatment: The onward march below the knee

Watch Now
Short cuts

BTK disease: Finding the path to a successful DCB for below-knee treatment

Watch Now
In Focus

How below-knee PAD treatment space is opening up after LIFE-BTK

Watch Now
SPONSORED In conversation

“Unique” SirPAD trial demonstrates superiority of sirolimus-coated balloon in all-comer population

Watch Now
Short cuts

“What we saw in the final results was the least desirable for me as a researcher”

Watch Now

In focus

In Focus

New frontiers in CLTI treatment: The onward march below the knee

7 July 2026
In Focus

How below-knee PAD treatment space is opening up after LIFE-BTK

2 July 2026
In Focus

“Nothing but zeros”: Post-CREST-2, are innovative carotid stent designs set to shift the treatment landscape?

19 June 2026
In Focus

Hitting the target: A prescription for precision thromboprophylaxis to prevent amputation

19 June 2026
In Focus

State of PAD care in 2026: Greenhalgh Lecturer issues rallying cry for multidisciplinary teamwork to better serve patient needs

5 June 2026
In Focus

How European guidelines are helping re-shape vascular trauma treatment

1 June 2026
SPONSORED In Focus

Why IVUS adds value in PAD procedures

5 May 2026
In Focus

Fresh data point to a new era of aortic training for vascular surgery trainees

29 April 2026

In conversation

SPONSORED In conversation

“Unique” SirPAD trial demonstrates superiority of sirolimus-coated balloon in all-comer population

1 July 2026
In conversation

Drug-coated technology in PAD, part two: Safety, limus and beyond

30 June 2026
In conversation

Juxtarenal and complex AAA: Getting to the right option

22 June 2026
In conversation

The death and re-birth of endoAVF systems, part two: “With every experiment, you will encounter a degree of failure”

16 June 2026
In conversation

Drug-coated technology in PAD, part one: Where are we now?

12 June 2026
In conversation

The death and re-birth of endoAVF systems, part one: “The only thing that stifled it was withdrawal from the market”

3 June 2026
In conversation

CX 2025: Expert panellists spotlight CLTI challenges and solutions

30 January 2026
SPONSORED In conversation

Experts agree: when lesion type changes the equation for DCB

29 January 2026

Webinars

Webinars

Vascular News Live: Aortic Roundtable Discussion

25 March 2025
Webinars

Vascular News Live: Pressing challenges and hot topics in vascular access

13 March 2025
Webinars

Vascular News Live: Pressing challenges and hot topics in CLTI and PAD

7 March 2025
SPONSORED Webinars

GORE® ACTIVE CONTROL System: “A system for the masses”

11 May 2021
SPONSORED Webinars

WavelinQ™ 4F EndoAVF System – An attractive non-surgical AV fistula option for dialysis patients

18 December 2020
SPONSORED Webinars

Webinar: Safety of paclitaxel devices—What does the evidence say?

2 August 2019

Short cuts

Short cuts

BTK disease: Finding the path to a successful DCB for below-knee treatment

2 July 2026
Short cuts

“What we saw in the final results was the least desirable for me as a researcher”

30 June 2026
Short cuts

Off the shelf, custom or PMEG? World experts debate juxtarenal and complex AAA approaches

22 June 2026
Short cuts

CX paclitaxel roundtable: “The benefits might have been a bit overstated”

12 June 2026
Short cuts

Quality PAD care for patients “wherever they are”

5 June 2026
Short cuts

“Read the guidelines”: ESVS document helps to move vascular trauma space

1 June 2026
Short cuts

Predicting rupture in the aorta: ‘Using one biomarker is quite poor’

28 January 2026
Short cuts

LIFE-BTK: Improving durability with bioresorbable technology

25 October 2023
Vascular News

Write to us
Editor: Jocelyn Hudson [email protected]
Advertising: Nathalie Fortin [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

Terms and Conditions | Privacy Policy

Facebook Linkedin Mail Twitter Youtube